Announcement of the Resolutions of the 2025 Annual Shareholders Meeting of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Securities code: 603567 Securities abbreviation: Zhenbaodao Announcement number: Lin 2026-050
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 2025 Annual Shareholders Meeting
The company and all members of the board of directors guarantee that there are no false records, misleading statements or major omissions in the announcement content, and assume legal responsibility for the authenticity, accuracy and completeness of its content.
Important content reminder:
Is there any veto resolution at this meeting: None
1. Meeting convening and attendance
(1) Time of the shareholders’ meeting: May 25, 2026
(2) The location of the shareholders’ meeting: No. 8, Yantai 1st Road, Pingfang Development Zone, Harbin
(3) Common shareholders attending the meeting and preference shareholders whose voting rights have been restored and their holdings:
Number of shareholders and proxies attending the meeting 228
Total number of shares with voting rights held by shareholders attending the meeting (shares) 477,553,524
The number of voting shares held by shareholders attending the meeting accounts for the company’s voting shares.
Proportion of 50.7572 total copies (%)
(4) Whether the voting method complies with the provisions of the "Company Law" and the "Articles of Association", the status of the meeting, etc.
This meeting was convened by the company's board of directors and chaired by Mr. Yan Jiujiang, the company's chairman. This meeting voted on the matters listed in the notice of shareholders’ meeting through a combination of on-site and online voting. The voting method complied with the provisions of the Company Law and the Articles of Association.
(5) Attendance of company directors and board secretary
The company has 5 current directors and 5 non-voting directors;
The secretary of the board of directors and senior managers attended this meeting.
2. Proposal review status
(1) Non-cumulative voting proposals
- Proposal Name: 2025 Board of Directors Work Report
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder Type Proportion Proportion Number of Votes Number of Votes Number of Votes
(%) (%) (%)
A shares 476,110,024 99.6977 1,302,000 0.2726 141,500 0.0297
- Proposal name: Full text and summary of "2025 Annual Report"
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder Type Proportion Proportion Number of Votes Number of Votes Number of Votes
(%) (%) (%)
A shares 472,964,155 99.0390 4,431,969 0.9281 157,400 0.0329
- Proposal Name: 2025 Profit Distribution Plan
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder Type Proportion Proportion Number of Votes Number of Votes Number of Votes
(%) (%) (%)
A shares 476,075,924 99.6906 1,329,200 0.2783 148,400 0.0311
- Proposal Name: Proposal on Applying for Credit Lines and Financing from Financial Institutions in 2026
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder Type Proportion Proportion Number of Votes Number of Votes Number of Votes
(%) (%) (%)
A shares 476,014,724 99.6778 1,437,500 0.3010 101,300 0.0212
- Proposal name: Proposal on the remuneration of directors and senior managers in 2025 and the remuneration plan for 2026
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder Type Proportion Proportion Number of Votes Number of Votes Number of Votes
(%) (%) (%)
A shares 476,034,424 99.6819 1,416,800 0.2967 102,300 0.0214
- Proposal Name: Proposal on Amending the "Code of Conduct for Controlling Shareholders and Actual Controllers"
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder Type Proportion Proportion Number of Votes Number of Votes Number of Votes
(%) (%) (%)
A shares 472,936,255 99.0331 4,507,169 0.9438 110,100 0.0231
(2) Voting status of cumulative voting proposals
- Proposal on the General Election of the Board of Directors and Nomination of Non-Independent Director Candidates for the Sixth Board of Directors
Votes accounted for attendance
Proposal serial number Proposal name Number of votes Valid voting at the meeting Whether elected or not
proportion of power
(%)
7.01 Fang Fuxin 473,754,371 99.2044 Yes
7.02 Yan Jiujiang 474,320,046 99.3229 Yes
7.03 Zheng Song 474,315,353 99.3219 Yes
- The motion regarding the general election of the Board of Directors and the nomination of independent director candidates for the sixth Board of Directors accounted for the number of votes present
Valid voting at the meeting
Motion number, motion name, number of votes, proportion of whether or not to be elected
(%)
8.01 Wang Zhiqun 474,335,447 99.3261 Yes
8.02 Zhang Tieming 474,315,343 99.3219 Yes
(3) When major matters are involved, the voting status of shareholders below 5%
- Non-cumulative voting proposals
Agree Objection Abstain motion
Proposal name Proportion Proportion Proportion number Number of votes Number of votes Number of votes (%) (%) (%) Profit for 2025
3 6,085,009 80.4617 1,329,200 17.5759 148,400 1.9624Profit distribution plan
About Director, Gao
senior managers
2025 annual salary
5 Remuneration situation and 6,043,509 79.9130 1,416,800 18.7342 102,300 1.3528 2026 annual salary
Negotiation of remuneration plan
case
- Cumulative voting proposals
(1) Proposal on the General Election of the Board of Directors and Nomination of Non-Independent Director Candidates for the Sixth Board of Directors
Votes accounted for attendance
Valid voting at the meeting
Motion number, motion name, number of votes, proportion of whether or not to be elected
(%)
7.01 Fang Fuxin 3,763,456 49.7639 Yes 7.02 Yan Jiujiang 4,329,131 57.2438 Yes 7.03 Zheng Song 4,324,438 57.1818 Yes
(2) Proposal on the General Election of the Board of Directors and Nomination of Independent Director Candidates for the Sixth Board of Directors
Votes accounted for attendance
Valid voting at the meeting
Motion number, motion name, number of votes, proportion of whether or not to be elected
(%)
8.01 Wang Zhiqun 4,344,532 57.4475 Yes
8.02 Zhang Tieming 4,324,428 57.1816 Yes
(4) Explanation of relevant circumstances regarding voting on motions
There are 5 resolutions involving related shareholders' avoidance of voting at this shareholders' meeting. Directors and senior managers who hold the company's shares and shareholders related to them shall refrain from voting on Proposal 5. This shareholders' meeting has listened to the 2025 independent directors' performance report from the company's independent directors.
3. Lawyer’s testimony
(1) Law firm witnessing this shareholder meeting: Beijing Lantai Law Firm
Lawyers: Zhang Buyong, Wang Ting
(2) Lawyer’s concluding comments:
The convening and holding procedures of this shareholders' meeting of the company comply with the provisions of the "Company Law" and other laws, administrative regulations, "Rules for Shareholders' Meetings of Listed Companies" and "Articles of Association"; the qualifications of the convener of this shareholders' meeting and the qualifications of attendees are legal and valid; the voting procedures and voting results of this shareholders' meeting are legal and valid.
Announcement is hereby made.
Board of Directors of Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
May 26, 2026